Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life After a First Ischemic Stroke

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Mar 22

PMID 26999113

Citations 15

Authors

Jose Alvarez-Sabin

Estevo Santamarina

Olga Maisterra

Carlos Jacas

Carlos Molina

Manuel Quintana

Affiliations

Soon will be listed here.

Abstract

Stroke, as the leading cause of physical disability and cognitive impairment, has a very significant impact on patients' quality of life (QoL). The objective of this study is to know the effect of citicoline treatment in Qol and cognitive performance in the long-term in patients with a first ischemic stroke. This is an open-label, randomized, parallel study of citicoline vs. usual treatment. All subjects were selected 6 weeks after suffering a first ischemic stroke and randomized into parallel arms. Neuropsychological evaluation was performed at 1 month, 6 months, 1 year and 2 years after stroke, and QoL was measured using the EuroQoL-5D questionnaire at 2 years. 163 patients were followed during 2 years. The mean age was 67.5 years-old, and 50.9% were women. Age and absence of citicoline treatment were independent predictors of both utility and poor quality of life. Patients with cognitive impairment had a poorer QoL at 2 years (0.55 vs. 0.66 in utility, p = 0.015). Citicoline treatment improved significantly cognitive status during follow-up (p = 0.005). In conclusion, treatment with long-term citicoline is associated with a better QoL and improves cognitive status 2 years after a first ischemic stroke.

Citing Articles

Efficacy analysis of neuroprotective drugs in patients with acute ischemic stroke based on network meta-analysis.

Li M, Huo X, Chang Q, Liu X, Zhang J, Mao Z Front Pharmacol. 2024; 15:1475021.

PMID: 39575393 PMC: 11578817. DOI: 10.3389/fphar.2024.1475021.

Effect of ginkgo diterpene lactone meglumine on the quality of life in patients with acute ischemic stroke.

Tian X, Xu Q, Xia X, Zhang Y, Zhao X, Wang A Health Qual Life Outcomes. 2024; 22(1):99.

PMID: 39548582 PMC: 11568673. DOI: 10.1186/s12955-024-02315-1.

Endogenous defense mechanism-based neuroprotection in large-vessel acute ischemic stroke: A hope for future.

Goel D, Shangari S, Mittal M, Bhat A Brain Circ. 2024; 10(1):51-59.

PMID: 38655439 PMC: 11034449. DOI: 10.4103/bc.bc_56_23.

Efficacy of citicoline as a supplement in glaucoma patients: A systematic review.

Prinz J, Prokosch V, Liu H, Walter P, Fuest M, Migliorini F PLoS One. 2023; 18(9):e0291836.

PMID: 37768938 PMC: 10538785. DOI: 10.1371/journal.pone.0291836.

A systematic review and meta-analysis of health utility values among patients with ischemic stroke.

Zhou J, Wei Q, Hu H, Liu W, Guan X, Ma A Front Neurol. 2023; 14:1219679.

PMID: 37731850 PMC: 10507900. DOI: 10.3389/fneur.2023.1219679.

References

Lopez-Bastida J, Oliva Moreno J, Worbes Cerezo M, Perestelo Perez L, Serrano-Aguilar P, Monton-Alvarez F . Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain. BMC Health Serv Res. 2012; 12:315. PMC: 3468368. DOI: 10.1186/1472-6963-12-315. View

Diederich K, Frauenknecht K, Minnerup J, Schneider B, Schmidt A, Altach E . Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke. 2012; 43(7):1931-40. DOI: 10.1161/STROKEAHA.112.654806. View

Gutierrez-Fernandez M, Rodriguez-Frutos B, Fuentes B, Vallejo-Cremades M, Alvarez-Grech J, Exposito-Alcaide M . CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int. 2012; 60(3):310-7. DOI: 10.1016/j.neuint.2011.12.015. View

Christensen M, Mayer S, Ferran J . Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2009; 40(5):1677-82. DOI: 10.1161/STROKEAHA.108.538967. View

Pinto E, Maso I, Pereira J, Fukuda T, Seixas J, Menezes D . Differential aspects of stroke and congestive heart failure in quality of life reduction: a case series with three comparison groups. Health Qual Life Outcomes. 2011; 9:65. PMC: 3162523. DOI: 10.1186/1477-7525-9-65. View

Luengo-Fernandez R, Gray A, Bull L, Welch S, Cuthbertson F, Rothwell P . Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study. Neurology. 2013; 81(18):1588-95. PMC: 3806919. DOI: 10.1212/WNL.0b013e3182a9f45f. View

Wang Y, Pan Y, Zhao X, Wang D, Johnston S, Liu L . Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: finding from the CHANCE trial. CNS Neurosci Ther. 2014; 20(12):1029-35. PMC: 6493002. DOI: 10.1111/cns.12329. View

Ekvall Hansson E, Beckman A, Wihlborg A, Persson S, Troein M . Satisfaction with rehabilitation in relation to self-perceived quality of life and function among patients with stroke - a 12 month follow-up. Scand J Caring Sci. 2012; 27(2):373-9. DOI: 10.1111/j.1471-6712.2012.01041.x. View

Hornslien A, Sandset E, Bath P, Wyller T, Berge E . Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial. Stroke. 2013; 44(7):2022-4. DOI: 10.1161/STROKEAHA.113.001022. View

10.

Hurtado O, Cardenas A, Pradillo J, Morales J, Ortego F, Sobrino T . A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis. 2007; 26(1):105-11. DOI: 10.1016/j.nbd.2006.12.005. View

11.

Sobrino T, Rodriguez-Gonzalez R, Blanco M, Brea D, Perez-Mato M, Rodriguez-Yanez M . CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res. 2011; 33(6):572-7. DOI: 10.1179/016164110X12807570510176. View

12.

Badia X, Roset M, Montserrat S, Herdman M, Segura A . [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc). 2000; 112 Suppl 1:79-85. View

13.

Bushnell C, Reeves M, Zhao X, Pan W, Prvu-Bettger J, Zimmer L . Sex differences in quality of life after ischemic stroke. Neurology. 2014; 82(11):922-31. PMC: 4211921. DOI: 10.1212/WNL.0000000000000208. View

14.

Feigin V, Forouzanfar M, Krishnamurthi R, Mensah G, Connor M, Bennett D . Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014; 383(9913):245-54. PMC: 4181600. DOI: 10.1016/s0140-6736(13)61953-4. View

15.

Royall D, Lauterbach E, Kaufer D, Malloy P, Coburn K, Black K . The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2007; 19(3):249-65. DOI: 10.1176/jnp.2007.19.3.249. View

16.

Fischer U, Anca D, Arnold M, Nedeltchev K, Kappeler L, Ballinari P . Quality of life in stroke survivors after local intra-arterial thrombolysis. Cerebrovasc Dis. 2008; 25(5):438-44. DOI: 10.1159/000126917. View

17.

Osman A, Porritt M, Nilsson M, Kuhn H . Long-term stimulation of neural progenitor cell migration after cortical ischemia in mice. Stroke. 2011; 42(12):3559-65. DOI: 10.1161/STROKEAHA.111.627802. View

18.

Dorman P, Waddell F, Slattery J, Dennis M, Sandercock P . Is the EuroQol a valid measure of health-related quality of life after stroke?. Stroke. 1997; 28(10):1876-82. DOI: 10.1161/01.str.28.10.1876. View

19.

Bramanti V, Campisi A, Tomassoni D, Volti G, Caccamo D, Cannavo G . Effect of acetylcholine precursors on proliferation and differentiation of astroglial cells in primary cultures. Neurochem Res. 2008; 33(12):2601-8. DOI: 10.1007/s11064-008-9829-z. View

20.

Herdman M, Badia X, Berra S . [EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care]. Aten Primaria. 2001; 28(6):425-30. PMC: 7684037. DOI: 10.1016/s0212-6567(01)70406-4. View